Boehringer Ingelheim GmbH
External Communications
Ute E. Schmidt
55216 Ingelheim
Germany
Value through Innovation17 January 2013
24 September 2008
Landmark UPLIFT® study reaffirms the safety of Spiriva® (tiotropium) in patients with Chronic Obstructive Pulmonary Disease
Professor Marc Decramer, University of Leuven, Belgium published safety analysis of tiotropium.
For further information please see the news release issued today by Prof. Marc Decramer, Katholieke Universiteit Leuven, Belgium.
Related COPD Press Releases
| page | 03 September 2012 COPD |
|---|---|
| page | 03 September 2012 Spiriva |
| page | 15 June 2011 COPD |
